The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
25 women students to receive internship, training, and mentorship in Life Sciences segment
Bayer expects 2025 to be the most difficult year of its turnaround
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Subscribe To Our Newsletter & Stay Updated
